Comments

CRISPR Therapeutics

CRSPNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$48.32
0.140.29%
Pre-Market: Sep 20, 7:50 PM EDT
15 minutes delayed
CRISPR Therapeutics (CRSP) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

CRISPR Therapeutics (NASDAQ:CRSP) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for CRISPR Therapeutics (CRSP)?

A

There have been no specific sales or earnings guidance reported for CRISPR Therapeutics in recent months.

Browse guidance and forecast on all stocks.